Patrick Gavin, DO
Urology · Richland, WANPI 1861620627
Payments from drug & device makers
Across 44 payments — averaging $80.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$2K
- C. R. Bard, Inc. & Subsidiaries$246
- Teleflex LLC$132
- Axonics, Inc.$120
- Coloplast$113
- Boston Scientific$112
- plus $412 from 9 others
What the payments were for
- Travel & lodging$1,81651%
- Food & beverage$1,71849%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 13 | $2,402 |
| C. R. Bard, Inc. & Subsidiaries | 10 | $246 |
| Teleflex LLC | 1 | $132 |
| Axonics, Inc. | 1 | $120 |
| Coloplast | 2 | $113 |
| Boston Scientific | 3 | $112 |
| Johnson & Johnson | 1 | $93 |
| Olympus America Inc. | 2 | $69 |
| Urogen Pharma, Inc. | 2 | $58 |
| 180 Medical, Inc. | 2 | $52 |
| Endo Pharmaceuticals Inc. | 2 | $47 |
| BD | 2 | $44 |
| Ferring Pharmaceuticals Inc. | 1 | $32 |
| Laborie Medical Technologies Corp. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$1,963
- AquaBeam Robotic System$137
- UroLift System$132
- Axonics$120
- TITAN$101
How this compares
$3,538 in reported general payments places this provider in the 60th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 14 | $7,891 |
| Estradiol | 114 | $7,614 |
| Finasteride | 389 | $6,137 |
| Tamsulosin Hcl | 291 | $3,745 |
| Dutasteride | 17 | $770 |
| Oxybutynin Chloride | 14 | $301 |
| Tramadol Hcl | 97 | $298 |
| Ciprofloxacin Hcl | 100 | $276 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $29 |
Paid to pharmacies, not to this prescriber.
Other urology in Richland
- Julio SlongoRichland$8K
- James PorterSeattle$2.6M
- Shane PearceSpokane$1.8M
- Raymond LanceSpokane$1.2M
- Jonathan WrightSeattle$1M
- Thomas WalshSeattle$388K
- Una LeeSeattle$236K
- Marah HehemannSeattle$213K
- Sarah PsutkaSeattle$185K
- Alvaro LucioniSeattle$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.